| Title: | Multi-system diseases and death trajectory of metabolic dysfunction-associated fatty liver disease |
| Lead Institution: | West China Hospital of Sichuan University |
| Principal investigator: |
Application 112111
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
About
Metabolic dysfunction-associated fatty liver disease (MAFLD) is a newly defined condition encompassing hepatic steatosis and metabolic dysfunction. However, the relationship between MAFLD and multisystem diseases remains unclear, and the time-dependent sequence of these diseases requires further clarification. Therefore, using disease trajectory analysis will identified a range of increased risks of medical conditions and causes of death for individuals with MAFLD. Developing relevant intervention measures that target these key pathways may benefit the MAFLD population by preventing a decline in general health.1 Publication
| Pub ID | Title | Author(s) | Year | Journal |
|---|---|---|---|---|
| 9261 | Association between metabolic dysfunction-associated fatty liver disease and abdominal aortic aneurysm: findings from the UK Biobank cohort | Yu Jia (+9) | 2023 | Nutrition Metabolism and Cardiovascular Diseases |
Enabling scientific discoveries that improve human health